Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesMeta-analysis of doripenem vs comparators in patients with pseudomonas infections enrolled in four phase III efficacy and safety clinical trials
Current Medical Research and Opinion, 10/27/09
Jenkins SG et al. – The weighted difference in clinical success rates for subjects with cIAI and NP/VAP infections caused by P. aeruginosa was in favor of doripenem, with the relative benefit of doripenem compared with the comparator agents similar across the two infections.
Related Articles
Large Dissemination of VIM-2 Metallo-beta-Lactamase-Producing Pseudomonas aeruginosa Causing Healthcare-Associated Community-Onset Infections
Journal of Clinical Microbiology, 10/08/09
Relevance Score: 67%
Frequency of Pseudomonas aeruginosa Colonizations/Infections in Lung Transplant Recipients
Transplantation Proceedings, 11/13/09
Relevance Score: 66%
Gileads Aztreonam for Inhalation Solution to be Reviewed by FDA Anti-Infective Drugs Advisory Committee on December 2009
Gilead, 10/27/09
Relevance Score: 66%
Exit Site Infections: Systematic Microbiologic and Quality Control Are Needed
Advances in Peritoneal Dialysis, 10/21/09
Relevance Score: 66%
Emerging Infections in Burns
Surgical Infections, 10/08/09
Relevance Score: 66%
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Therapeutic Drug Monitoring of Posaconazole: a Monocentric Study with 54 Adults
Antimicrobial Agents and Chemotherapy, 11/20/09
Mutations in Ribosomal Protein L3 Are Associated with Oxazolidinone Resistance in Staphylococci of Clinical Origin
Antimicrobial Agents and Chemotherapy, 11/20/09
Transcriptomic Profiling of the Saccharomyces cerevisiae Response to Quinine Reveals a Glucose Limitation Response Attributable to Drug-Induced Inhibition of Glucose Uptake
Antimicrobial Agents and Chemotherapy, 11/20/09
Today in Drug Interactions...keeping you current
Receive free subspecialty "5-minute updates" via email
Antiretroviral and Immunosuppressive Drug-Drug Interactions in Human Immunodeficiency Virus-Infected Liver and Kidney Transplant Recipients
Transplantation Proceedings, 11/20/09
If the KI is defined by the free energy of binding to P-gp, what kinetic parameters define the IC50 for the MDCKII-hMDR1 confluent cell monolayer
Drug Metabolism and Disposition, 11/20/09
Nifekalant versus lidocaine for in-hospital shock-resistant ventricular fibrillation or tachycardia
Resuscitation, 11/18/09
Sponsor
Article Search
Sponsor